(Total Views: 534)
Posted On: 01/11/2021 10:39:09 PM
Post# of 154003
CDIddy,
The secondary endpoints are clinically very important.
If Cytodyn missed primary endpoint (again phase 3/registrational), I would expect EUA and another trial to obtain full approval.
That is unless Cytodyn gets the Gilead Remdesivir red carpet treatment (sarcasm intended in consideration of the last few months).
The secondary endpoints are clinically very important.
If Cytodyn missed primary endpoint (again phase 3/registrational), I would expect EUA and another trial to obtain full approval.
That is unless Cytodyn gets the Gilead Remdesivir red carpet treatment (sarcasm intended in consideration of the last few months).
(2)
(0)
